Quote | Treace Medical Concepts Inc. (NASDAQ:TMCI)
Last: | $6.63 |
---|---|
Change Percent: | 0.46% |
Open: | $6.46 |
Close: | $6.63 |
High: | $6.715 |
Low: | $6.35 |
Volume: | 475,565 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Treace Medical Concepts Inc. (NASDAQ:TMCI)
2024-06-17 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-14 11:19:03 ET Summary Treace Medical Concepts, Inc. stock plummeted 63% after revising the FY24 outlook due to competitive pressure from MIS osteotomy devices and knockoff Lapiplasty products. Treace's Lapiplasty 3D Bunion Correction System offers a superior solution to t...
Message Board Posts | Treace Medical Concepts Inc. (NASDAQ:TMCI)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Treace Medical Concepts Inc. Company Name:
TMCI Stock Symbol:
NASDAQ Market:
Treace Medical Concepts Inc. Website:
2024-06-17 13:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PONTE VEDRA, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its fla...
NEW YORK, NY / ACCESSWIRE / May 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace securities are encouraged to obtain additional in...